Last updated on September 2016

CONVERGE


Brief description of study

CONVERGE

Detailed Study Description

This study is evaluating 2 different treatment options for persistent atrial fibrillation. In this multi-center, pivotal clinical study, patients are randomized (2:1) to either a convergent procedure that includes both epicardial and endocardial atrial ablation versus standalone endocardial catheter ablation. The study will enroll and randomize one hundred and fifty three (153) patients from up to thirty (30) sites with twenty-seven (27) in the US and three (3) sites OUS.

Clinical Study Identifier: TX11446

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Jessica Marsh, RN

Heart Center Research LLC
Huntsville, AL USA
  Connect »

Shine Y. Kim, BSN, RN

MedStar Washington Hospital Center
Washington, DC USA
  Connect »

Cynthia Barnes, RN

Emory University - St. Joseph's Hospital
Atlanta, GA USA
  Connect »

Sara Simpkiss

St. Vincent Medical Group Inc.
Indianapolis, IN USA
  Connect »

Becky Toler, RN, BSN

Cardiovascular Research Foundation of Louisiana
Baton Rouge, LA USA
  Connect »

Jean Byrne, RN

Lahey Clinic
Burlington, MA USA
  Connect »

Sandra Watt, RN

Genesys Regional Medical Center
Grand Blanc, MI USA
  Connect »

Angela Long, RN

Cardiology Associates Research, LLC
Tupelo, MS USA
  Connect »

Melanee Tomasulo, RN BSN

Cary Research Group, LLC/Wake Medical Center
Raleigh, NC USA
  Connect »

KeriAnn Shuman, RN

Summa Health System
Akron, OH USA
  Connect »

Barbara Fortanely, RN, CCRP

Austin Heart PLLC
Austin, TX USA
  Connect »

DD Castillo

STAR Clinical Trials LLC
San Antonio, TX USA
  Connect »

Laura Puckett, RN

Virginia Cardiovascular Specialists
Richmond, VA USA
  Connect »